Subscribe To

Price Alert Latest News Economic Calendar News

AFIB / Acutus Medical to Announce Fourth Quarter and Full-Year Financial Results

CARLSBAD, Calif., March 10, 2022 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, announced today that it will release its fourth quarter and full-year 2021 financial results on Thursday, March 17, 2022. In conjunction with the release, Acutus will host a conference call and webcast that day at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its financial results and recent highlights. Read More

Demo Live Account See Partner Details

Content Topics

Acutus

Medical

Announce

Fourth

Quarter

Full

Year

Financial

Full year

Results

Stock

AFIB

Posted: Mar 10 2022, 16:01

Author Name: GlobeNewsWire

AFIB News

By GlobeNewsWire
November 2, 2023

Acutus Medical to Announce Third Quarter 2023 Financial Results

CARLSBAD, Calif., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on im

By Seeking Alpha
August 7, 2023

Acutus Medical, Inc. (AFIB) Q2 2023 Earnings Call Transcript

Acutus Medical, Inc. (NASDAQ:AFIB ) Q2 2023 Earnings Conference Call August 7, 2023 4:30 AM ET Company Participants Caroline Corner - IR David Roman -

By Zacks Investment Research
August 7, 2023

Acutus Medical, Inc. (AFIB) Reports Q2 Loss, Tops Revenue Estimates

Acutus Medical, Inc. (AFIB) came out with a quarterly loss of $0.63 per share versus the Zacks Consensus Estimate of a loss of $0.61. This compares to

By Seeking Alpha
May 11, 2023

Acutus Medical, Inc. (AFIB) Q1 2023 Earnings Call Transcript

Acutus Medical, Inc. (NASDAQ:AFIB ) Q1 2023 Earnings Conference Call May 11, 2023 4:30 PM ET Company Participants Caroline Corner - Investor Relations

By GlobeNewsWire
April 28, 2023

Acutus Medical to Announce First Quarter 2023 Financial Results

CARLSBAD, Calif., April 28, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on i

By Seeking Alpha
March 16, 2023

Acutus Medical, Inc. (AFIB) Q4 2022 Earnings Call Transcript

Start Time: 16:30 January 1, 0000 5:14 PM ET Acutus Medical, Inc. (NASDAQ:AFIB ) Q4 2022 Earnings Conference Call March 16, 2023, 16:30 PM ET Company

By GlobeNewsWire
March 9, 2023

Acutus Medical to Announce Fourth Quarter and Full Year 2022 Financial Results

CARLSBAD, Calif., March 09, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on i

By Seeking Alpha
November 13, 2022

Acutus Medical, Inc. (AFIB) Q3 2022 Earnings Call Transcript

Acutus Medical, Inc. (NASDAQ:AFIB ) Q3 2022 Earnings Conference Call November 10, 2022 4:30 PM ET Company Participants Caroline Corner - Investor Rela

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.